methylergonovine maleate

Generic: methylergonovine maleate

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name methylergonovine maleate
Generic Name methylergonovine maleate
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

methylergonovine maleate .2 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-735
Product ID 16571-735_6fc367d7-31bb-415b-bb35-367a81dd5bfa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211919
Listing Expiration 2026-12-31
Marketing Start 2021-01-15

Pharmacologic Class

Classes
ergolines [cs] ergot derivative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571735
Hyphenated Format 16571-735

Supplemental Identifiers

RxCUI
996824
UNII
IR84JPZ1RK

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name methylergonovine maleate (source: ndc)
Generic Name methylergonovine maleate (source: ndc)
Application Number ANDA211919 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .2 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (16571-735-01)
  • 7 TABLET in 1 BOTTLE (16571-735-17)
  • 12 TABLET in 1 BOTTLE (16571-735-21)
  • 28 TABLET in 1 BOTTLE (16571-735-28)
source: ndc

Packages (4)

Ingredients (1)

methylergonovine maleate (.2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6fc367d7-31bb-415b-bb35-367a81dd5bfa", "openfda": {"unii": ["IR84JPZ1RK"], "rxcui": ["996824"], "spl_set_id": ["465b292b-0e0e-4a55-894e-90234efe2a12"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-735-01)", "package_ndc": "16571-735-01", "marketing_start_date": "20210115"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE (16571-735-17)", "package_ndc": "16571-735-17", "marketing_start_date": "20210115"}, {"sample": false, "description": "12 TABLET in 1 BOTTLE (16571-735-21)", "package_ndc": "16571-735-21", "marketing_start_date": "20210115"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (16571-735-28)", "package_ndc": "16571-735-28", "marketing_start_date": "20210115"}], "brand_name": "Methylergonovine Maleate", "product_id": "16571-735_6fc367d7-31bb-415b-bb35-367a81dd5bfa", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "16571-735", "generic_name": "Methylergonovine Maleate", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Methylergonovine Maleate", "active_ingredients": [{"name": "METHYLERGONOVINE MALEATE", "strength": ".2 mg/1"}], "application_number": "ANDA211919", "marketing_category": "ANDA", "marketing_start_date": "20210115", "listing_expiration_date": "20261231"}